We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves GSK Melanoma Drugs, Epilepsy Drug Limited by EU
FDA Approves GSK Melanoma Drugs, Epilepsy Drug Limited by EU
June 7, 2013
U.K. pharma giant GlaxoSmithKline (GSK) took two steps forward and a small step back last month as the FDA approved two of its melanoma drugs, but EU regulators say they want to limit the use of an anti-seizure treatment it co-markets with Valeant Pharmaceuticals.